AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: D.Right who wrote (1336)	4/26/1998 9:27:00 AM
From: Rob	Read Replies (1) of 2173

To all: Yesterday I attended the Fidelity Investor Discovery Conference in Boston. I spoke briefly to Ken Kam of the Technology Value Fund (best performing mutual fund in the U.S. for past three years 60+ % annualized returns) who was extremely bullish on Amylin. He essentially said it was his favorite pick. I also spoke to Michael Murphy ( California Technology Stock Letter) who also apparently has Amylin on his favorites's list. I don't follow this stock but thought you'd want to know that there's some serious horsepower in silicon valley hoping for success with this company. In addition they mentioned that a new executive at Amylin has ties to Eli Lilly. Lilly wouldn't mind getting it's hands on something that J&J shouldered the development costs for. Good luck.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next